A study on a protein that helps maintain the blood-brain barrier and ameliorated the effects of a multiple sclerosis-like disease in an animal model.
Researchers at the IRCM led by Artur Kania, Professor in the Department of Medicine at the Université de Montréal, uncovered the critical role in pain processing of a gene associated with a rare disease. Their breakthrough, published in The Journal of Neuroscience, paves the way for a better understanding of chronic pain conditions. Continue reading
Read his profile: Michael Gordon – 2015 CAN Young Investigator
“A big challenge in treating stroke is understanding how other health conditions affect recovery,” says Craig Brown, a neuroscientist in UVic’s Division of Medical Sciences “Many diseases increase the chances of having a stroke, and they also limit recovery. Diabetes is one of these diseases, affecting millions in Canada. Much like a five-card poker hand, the unique collection of health concerns a patient holds in their hand likely dictates how they should be treated.” Continue reading
A team of researchers at the IRCM led by Michel Cayouette, PhD, identified one of the genes responsible for producing a type of cell required for vision. The breakthrough, published in the scientific journal Neuron, could eventually help overcome obstacles associated with treatments to prevent blindness. Continue reading
Years ago, children were warned that smoking could stunt their growth, but now a major study by an international team including the Montreal Neurological Institute at McGill University and the University of Edinburgh shows new evidence that long-term smoking could cause thinning of the brain’s cortex. Continue reading
Brain cancer patients may live longer thanks to a new cancer-detection method developed by researchers at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC, and Polytechnique Montréal. The collaborative team has created a powerful new intraoperative probe for detecting cancer cells. Continue reading
Canadian researchers have completed an international randomized controlled trial showing that a clot retrieval procedure, known as endovascular treatment (ET), can dramatically improve patient outcomes after an acute ischemic stroke. The study, led by researchers at the University of Calgary’s Hotchkiss Brain Institute (HBI), shows a dramatic improvement in outcomes and a reduction in deaths from stroke. The results of this study were published in the Feb. 11 online edition of the New England Journal of Medicine (NEJM).